Celebrex Passes Cardiac and Gastric Safety Test
The COX-2 inhibitor Celebrex (celecoxib) has been shown to be as effective for the treatment of osteoarthritis as are non-specific non-steroidal anti-inflammatory drugs (NSAIDs)....

Celebrex Approved to Treat Juvenile Rheumatoid Arthritis
The U.S. Food and Drug Administration (FDA) today approved Celebrex (celecoxib) for a new use â the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older....

Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer Chemoprevention Trial
HOUSTON, May 16, 2008 Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University...

Celebrex, Naproxen Won't Prevent Mental Decline
MONDAY, May 12 -- Contrary to prior studies, a new trial shows that daily use of two popular pain-relieving drugs, Celebrex and naproxen, does not prevent cognitive decline in people with a family history of Alzheimer's disease. In fact, naproxen, which goes under the...

Celebrex May Reduce Levels of Lung Cancer Biomarker
SUNDAY, June 1 -- A widely prescribed pain reliever may one day have value in helping to prevent lung cancer. Researchers report that Celebrex (celecoxib), the last remaining cox-2 inhibitor on the U.S. market, may reduce levels of a biomarker indicating risk for this deadly disease....

Celebrex Plus Lipitor Could Fight Prostate Cancer
...prostate cancer. New research being presented at the American Association for Cancer Research annual meeting in San Diego finds that the painkiller Celebrex and the statin Lipitor, when used together or alone, can stop early prostate cancer before it becomes deadly. The study was conducted in mice...

Pfizer statement: One of two studies shows Celebrex patients having increased risk of heart attacks
NEW YORK, N.Y., December 17 -- Pfizer Inc said it received new information Thursday about the cardiovascular safety of its COX-2 inhibitor Celebrex (celecoxib), based on an analysis of two long-term cancer trials. The company released the following statement: As reported to Pfizer by the Data...

Public Citizen Calls on FDA to Stop Illegal Celebrex Television Advertisement
...of Public Citizens Health Research Group, urging the FDA to order Pfizer to immediately stop its misleading 2 ½ minute television advertisement for Celebrex that began airing on April 2nd. The letter faults the Celebrex ad for: asserting, contrary to scientific evidence, that the cardiovascular dangers...

FDA Approves New Use for Pfizer's Celebrex
NEW YORK, August 1, 2005 -- Pfizer Inc said today that the U.S. Food and Drug Administration has approved the companys selective COX-2 inhibitor Celebrex (celecoxib) for the relief of the signs and symptoms associated with ankylosing spondylitis, a form of arthritis that affects the spine. Celebrex...

Pfizer Wins Key New York State Court Ruling on Celebrex
...- Pfizer Inc announced today that a New York state court ruled in favor of the company on an important motion relating to litigation over Pfizer's Celebrex medication. New York Supreme Court Justice Shirley W. Kornreich ruled that the plaintiffs suing Pfizer in New York failed to present reliable...

See also: Ankylosing Spondylitis, Familial Adenomatous Polyposis, Fibromatosis, Juvenile Rheumatoid Arthritis, Osteoarthritis, Pain, Period Pain, Rheumatoid Arthritis

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.